It is perfectly comprehended that IL-2 is often a pleiotropic cytokine positioned in the crossroads of T cell activation and regulation. As a result, it can be crucial to engineer an IL-2 molecule that is biased to effector cells bearing the intermediate affinity receptor, including naïve and memory CD8+ T cells and NK cells, versus Treg cells tha